Sample results26 results in the last year.

Vonoprazan with amoxicillin or amoxicillin and clarithromycin for the treatment of Helicobacter pylori infection

L Liu, MC Nahata�- Annals of Pharmacotherapy, 2023
Objectives: To describe the pharmacology, efficacy, safety, and potential role of
vonoprazan with amoxicillin or amoxicillin and clarithromycin for the treatment of
Helicobacter pylori infection in adults. Data Sources: PubMed, Embase, Cochrane�…

Eradication Therapy for Helicobacter pylori Infection in Patients Receiving Hemodialysis

S Sahara, M Sugimoto, M Murata, E Iwata, T Kawai…�- Helicobacter, 2024
Patients receiving hemodialysis (HD) often develop gastrointestinal diseases.
Recently, although in general population, clinical guidelines for Helicobacter pylori
have strongly recommended its eradication in patients to prevent gastric cancer�…

Antibiotic resistance of Helicobacter pylori in Turkey: A systematic review and meta-analysis

M Ayaş, Y G�rol�- Microbial Drug Resistance, 2023
Turkey presents both a high prevalence of Helicobacter pylori infection and high
prevalence of antibiotic resistance. In this study, we aimed to summarize recent data
on H. pylori antibiotic resistance rates in this nation. After conducting searches in two�…

Helicobacter pylori eradication reduces risk for recurrence of gastric hyperplastic polyp after endoscopic resection

YS Cho, SY Nam, HS Moon, TH Kim, SE Kim, JT Jung�- The Korean journal of internal�…, 2023
Methods We retrospectively reviewed the medical records of 201 patients with H.
pylori infection who underwent endoscopic resection for gastric hyperplastic polyps
at six medical centers. H. pylori status was assessed by histological analysis and a�…

Vonoprazan on the eradication of Helicobacter pylori infection

J Huang, Y Lin�- The Turkish Journal of Gastroenterology, 2023
Background: This study aimed to investigate the efficacy and safety of vonoprazan in
the eradication of Helicobacter pylori (H. pylori). Methods: A total of 120 cases of H.
pylori-infected outpatients were selected and randomly divided into the traditional�…

Vonoprazan and high‐dose amoxicillin dual therapy for Helicobacter pylori first‐line eradication: a single‐arm, interventional study

S Sue, M Kondo, T Sato, H Oka, K Sanga, T Ogashiwa…�- JGH Open, 2023
Background To date, no interventional trial has assessed the efficacy and safety of
vonoprazan and high‐dose (500 mg four times daily, 2000 mg/day) amoxicillin dual
therapy in terms of Helicobacter pylori eradication. We explored whether this was an�…

Racial disparities of gastric cancer in the USA: an overview of epidemiology, global screening guidelines, and targeted screening in a heterogeneous population

JW Mok, YH Oh, D Magge, S Padmanabhan�- Gastric Cancer, 2024
Gastric cancer is the fifth most common cancer diagnosis and fourth leading cause of
cancer-related death globally. The incidence of gastric cancer in the USA shows
significant racial and ethnic disparities with gastric cancer incidence in Korean�…

Global research trends and hotspots of Helicobacter pylori eradication based on clinical trial registration platforms: A cross-sectional analysis

JL Guan, LN Feng, YY Han, SH Xia, K Zhao, MY Zhang…�- Clinics and Research in�…, 2023
Background This study aimed to obtain an overview of clinical trials on Helicobacter
pylori (H. pylori) eradication and analyze the global trends and hotspots in this field.
Methods We collected the data from clinical trials focused on H. pylori eradication in�…

Risk of upper gastrointestinal cancer and death in persons with negative screening results: results from the National Cancer Screening Program in South Korea

XQ Luu, K Lee, JK Jun, M Suh, KW Jung, IJ Choi…�- Gastric Cancer, 2023
Abstract Background The Korea National Cancer Screening Program (KNCSP) offers
upper endoscopy or upper gastrointestinal series (UGIS) biannually for people
aged≥ 40 years. This study aimed to assess the effect of negative screening results�…

Improvement of dyspeptic symptoms after Helicobacter pylori eradication therapy in Japanese patients

E Iwata, M Sugimoto, M Murata, Y Morino, Y Akimoto…�- JGH Open, 2023
Abstract Background and Aim Helicobacter pylori eradication therapy effectively
improves the abdominal symptoms and bowel habits of patients. Patients in whom
dyspepsia is under control by 6 to 12 months after successful H. pylori eradication�…